Geode Capital Management »

Catalyst Pharmaceutical Partners shares owned by Geode Capital Management

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2013-03-31 $47k 95k 0.49
2012-12-31 $41k 95k 0.43
2012-09-30 $109k 72k 1.50
2012-03-31 $18k 16k 1.10
2011-12-31 $21k 16k 1.28

More positions owned by Geode Capital Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Inc-class A Cl A (META)
Alphabet Inc-cl A Cap Stk Cl A (GOOGL)
Alphabet Inc-cl C Cap Stk Cl C (GOOG)
Berkshire Hathaway Inc-cl B Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Visa Inc-class A Shares Com Cl A (V)
UnitedHealth (UNH)
Exxon Mobil Corporation (XOM)

View all positions for Geode Capital Management

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners